Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption
- PMID: 8344334
- DOI: 10.1111/j.1365-2362.1993.tb02034.x
Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption
Abstract
The measurement of the 3-OH pyridinium compounds, pyridinoline (Pyr) and deoxypyridinoline (Dpyr), in urine by high performance liquid chromatography is potentially useful in clinical studies, since they are specific biochemical markers of bone resorption. The aims of the present study were to improve assay performance and optimize sample collection. An isocratic high performance liquid chromatogram (HPLC) separation with baseline resolution was accomplished within 4 min using heptafluorobutyric acid as an ion-pair. The sample preparation for HPLC, using CF1 cellulose, produced uncontaminated samples with a recovery higher than 90% for both crosslinks. An elastin-derived material, tentatively identified as isodesmosine (Ides), was also tested and proved to be a suitable internal standard. Use of this standard improved assay precision. The effect of an oral gelatin load on the excretion of Pyr and Dyr was investigated. The creatinine corrected excretion of Pyr and Dpyr was unchanged over a 6 h period, in contrast to the 10-fold increase in the excretion of urinary hydroxyproline with a peak 2-4 h after ingestion. In 20 postmenopausal women, 2 h fasting morning urine results correlated with results from 24-h urine collections Dpyr/Cr (r = 0.70, n = 20). There was a day-to-day variation of 26% in adults studied for 10 days.
Similar articles
-
Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: normal values and clinical application.Bone. 1996 Dec;19(6):669-77. doi: 10.1016/s8756-3282(96)00284-0. Bone. 1996. PMID: 8968036
-
Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks.Bone. 1998 Jan;22(1):73-8. doi: 10.1016/s8756-3282(97)00225-1. Bone. 1998. PMID: 9437516
-
Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?Bone Miner. 1993 Jul;22(1):1-8. doi: 10.1016/s0169-6009(08)80076-1. Bone Miner. 1993. PMID: 8219934
-
[Bone resorption markers].Rinsho Byori. 1996 May;44(5):415-22. Rinsho Byori. 1996. PMID: 8676559 Review. Japanese.
-
Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.Chin Med J (Engl). 2004 Feb;117(2):291-5. Chin Med J (Engl). 2004. PMID: 14975218 Review.
Cited by
-
An assessment of genetic markers as predictors of bone turnover in healthy adults.J Endocrinol Invest. 2001 Apr;24(4):236-45. doi: 10.1007/BF03343853. J Endocrinol Invest. 2001. PMID: 11383910 Clinical Trial.
-
Bone turnover markers: use in osteoporosis.Nat Rev Rheumatol. 2012 Jun 5;8(7):379-89. doi: 10.1038/nrrheum.2012.86. Nat Rev Rheumatol. 2012. PMID: 22664836 Review.
-
Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.Ann Rheum Dis. 1996 May;55(5):288-93. doi: 10.1136/ard.55.5.288. Ann Rheum Dis. 1996. PMID: 8660101 Free PMC article.
-
Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic Review.Bladder Cancer. 2021 Aug 31;7(3):365-376. doi: 10.3233/BLC-201526. eCollection 2021. Bladder Cancer. 2021. PMID: 38993611 Free PMC article.
-
Metabolic effects of pamidronate in patients with metastatic bone disease.Br J Cancer. 1996 May;73(9):1089-95. doi: 10.1038/bjc.1996.210. Br J Cancer. 1996. PMID: 8624269 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources